Hospital Acquired and Ventilator Associated Pneumonia Oncohema Key FDA approves new treatment for VAP Ventilator associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment Respiratory Medicine Risk Factors, Pathogens, and Outcomes of Ventilator Associated Pneumonia in Non Cardiac Surgical Patients: A Retrospective Analysis About Ventilator Associated Pneumonia (VAP) PROPHY VAP: Ceftriaxone to prevent early ventilator associated pneumonia The Bottom Line